Item Posts Archive - Page 30 of 1770 - Medivizor
Navigation Menu

Evaluating the benefits of allogeneic hematopoietic stem cell transplantation in childhood acute myeloid leukemia.

Evaluating the benefits of allogeneic hematopoietic stem cell transplantation in childhood acute myeloid leukemia.

Posted by on Feb 5, 2023 in Leukemia | 0 comments

In a nutshell This study analyzed the use of allogeneic hematopoietic stem cell transplantation (alloHSCT) therapy following first remission in children with newly diagnosed, high-risk acute myeloid leukemia (AML) compared to chemotherapy. This study supports the use of alloHSCT for children with AML that are at greater. Some background Childhood AML...

Read More

Safety and effectiveness of two different doses of daily-administered ABX464 in patients with unresponsive rheumatoid arthritis.

Safety and effectiveness of two different doses of daily-administered ABX464 in patients with unresponsive rheumatoid arthritis.

Posted by on Feb 5, 2023 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated the safety and effectiveness of ABX464 (Obefazimod) in patients with active rheumatoid arthritis (RA) with inadequate responses to methotrexate (Trexall) or anti-tumor necrosis factor alpha (anti-TNFα) treatment. The authors concluded that ABX464 was safe and well-tolerated with promising effectiveness in these...

Read More

Evaluating the effectiveness and safety of replacing lenalidomide with pomalidomide for the treatment of patients with multiple myeloma who are unresponsive to a lenalidomide-containing combination regimen.

Evaluating the effectiveness and safety of replacing lenalidomide with pomalidomide for the treatment of patients with multiple myeloma who are unresponsive to a lenalidomide-containing combination regimen.

Posted by on Feb 5, 2023 in Multiple Myeloma | 0 comments

In a nutshell This study evaluated the effectiveness and safety of replacing lenalidomide (Revlimid) with pomalidomide (Pomalyst) for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM) who were unresponsive to a lenalidomide-containing combination regimen. The data showed that pomalidomide was a safe and effective...

Read More

Evaluating the effectiveness and safety of microwave ablation therapy for the treatment of lung metastases in patients with colorectal cancer.

Evaluating the effectiveness and safety of microwave ablation therapy for the treatment of lung metastases in patients with colorectal cancer.

Posted by on Feb 5, 2023 in Colorectal cancer | 0 comments

In a nutshell This study evaluated the effectiveness and safety of microwave ablation (MWA) therapy for the treatment of lung metastases in patients with colorectal cancer (CRC). The data showed that MWA therapy might be a safe and effective option for these patients. Some background CRC is one of the most common types of cancer worldwide. Some...

Read More

Evaluating the effectiveness and safety of penpulimab in patients with relapsed or refractory classical Hodgkin lymphoma.

Evaluating the effectiveness and safety of penpulimab in patients with relapsed or refractory classical Hodgkin lymphoma.

Posted by on Feb 5, 2023 in Hodgkin's lymphoma | 0 comments

In a nutshell This study evaluated the effectiveness and safety of penpulimab (AK105) for the treatment of patients with relapsed or refractory (r/r) classical Hodgkin lymphoma (cHL). The data showed that penpulimab was effective and safe with manageable side effects in these patients. Some background Classical Hodgkin lymphoma (cHL) is a cancer of...

Read More